Locally administered bisphosphonate in hip stem revisions using the bone impaction grafting technique: a randomised, placebo-controlled study with DXA and five-year RSA follow-up.


Journal

Hip international : the journal of clinical and experimental research on hip pathology and therapy
ISSN: 1724-6067
Titre abrégé: Hip Int
Pays: United States
ID NLM: 9200413

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 23 6 2018
medline: 4 12 2019
entrez: 23 6 2018
Statut: ppublish

Résumé

Bisphosphonates have previously been shown to increase the density of impacted graft bone. In the present study we hypothesise that bisphosphonates also reduce early stem subsidence. We examined the effect of locally applied bisphosphonate to allografts on prosthetic micromotion and bone density in femoral stem revision with impaction grafting. 37 patients were randomised to either clodronate or saline as local adjunct to the morsellised allograft bone. 24 patients were finally analysed per protocol and evaluated by dual-energy x-ray absorptiometry (DXA) during the first year and with radiostereometric analysis (RSA) for 5 years. There were no significant differences neither in bone density, nor in migratory behaviour between the groups. The femoral stems had subsided 3.6 mm in both groups (p = 0.99) at 5 years and there was no difference as measured over time with mixed models analysis. The clinical outcome was good in both groups. Clodronate as a local addendum to allograft bone in hip revision did not increase bone density or reduce micromotion of the implant.

Sections du résumé

BACKGROUND: UNASSIGNED
Bisphosphonates have previously been shown to increase the density of impacted graft bone. In the present study we hypothesise that bisphosphonates also reduce early stem subsidence. We examined the effect of locally applied bisphosphonate to allografts on prosthetic micromotion and bone density in femoral stem revision with impaction grafting.
METHODS: UNASSIGNED
37 patients were randomised to either clodronate or saline as local adjunct to the morsellised allograft bone. 24 patients were finally analysed per protocol and evaluated by dual-energy x-ray absorptiometry (DXA) during the first year and with radiostereometric analysis (RSA) for 5 years.
RESULTS: UNASSIGNED
There were no significant differences neither in bone density, nor in migratory behaviour between the groups. The femoral stems had subsided 3.6 mm in both groups (p = 0.99) at 5 years and there was no difference as measured over time with mixed models analysis. The clinical outcome was good in both groups.
CONCLUSION: UNASSIGNED
Clodronate as a local addendum to allograft bone in hip revision did not increase bone density or reduce micromotion of the implant.

Identifiants

pubmed: 29932001
doi: 10.1177/1120700018781809
doi:

Substances chimiques

Bone Density Conservation Agents 0
Diphosphonates 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

26-34

Auteurs

Ola Belfrage (O)

1 Orthopaedics, Skåne University Hospital, Lund, Sweden.
2 Department of Clinical Sciences Lund, Lund University, Lund, Sweden.

Magnus Tägil (M)

1 Orthopaedics, Skåne University Hospital, Lund, Sweden.
2 Department of Clinical Sciences Lund, Lund University, Lund, Sweden.

Martin Sundberg (M)

1 Orthopaedics, Skåne University Hospital, Lund, Sweden.
2 Department of Clinical Sciences Lund, Lund University, Lund, Sweden.

Uldis Kesteris (U)

1 Orthopaedics, Skåne University Hospital, Lund, Sweden.
2 Department of Clinical Sciences Lund, Lund University, Lund, Sweden.

Gunnar Flivik (G)

1 Orthopaedics, Skåne University Hospital, Lund, Sweden.
2 Department of Clinical Sciences Lund, Lund University, Lund, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH